Business

Easton Pharmaceuticals Announces Update on Negotiations Towards Its Medical Marijuana Initiatives

Easton Pharmaceuticals Announces Update on Negotiations Towards Its Medical Marijuana Initiatives.

articleEaston Pharmaceuticals IncJanuary 16, 20144/company/easton-pharmaceutica/news/easton-pharmaceuticals-announces-update-on-negotiations-towards-its-medical-marijuana-initiatives
Easton Pharmaceuticals Announces Update on Negotiations Towards Its Medical Marijuana Initiatives

About this update from Easton Pharmaceuticals Inc

[{"type":"text","content":"\n \n \n Easton Pharmaceuticals Announces Update on Negotiations Towards Its Medical Marijuana Initiatives\n \n \nEaston Pharmaceuticals Announces Update on Negotiations Towards Its Medical Marijuana Initiatives\n \n TORONTO, ON--(Marketwired - Jan 16, 2014) -  Easton Pharmaceuticals Inc. (OTC: EAPH), a specialty pharmaceutical company that owns, designs, develops, and markets an array of topically-delivered drugs and therapeutic healthcare products, today announces an update to its previously announced Medical Marijuana initiatives.\n As previously disclosed in prior releases, Easton Pharmaceuticals in its quest to enter into new lucrative business segments and products, previously expressed its interest to enter into the medical marijuana industry in both the U.S. and Canadian Markets. Recent positive developments in the United States, Canada and other countries such as Uruguay have added fuel and optimism to the industry and what is possibly considered a vast and extremely profitable business for participants in this industry. Previous acquisitions made by Easton to enter into the Cancer drug Industry as well as moving forward with the company's current VIORRA initiatives in Mexico and in North America along with the company's other line of products, has directed the company to recently focus its priorities towards these two initiatives while awaiting for positive catalysts in the medical marijuana industry to materialize prior to making more concrete decisions towards Medical Marijuana. Due to the recent positive legal changes and attitudes towards Medical Marijuana and recreational Marijuana use in general, Easton Pharmaceuticals is speeding up negotiations with an Ontario, Canada based company towards forming a possible investment / partnership towards their Medical Marijuana initiatives which includes participating in their government application for both a growers and distributorship license in Canada and other possible international initiatives. This company has obtained some private financing allowing it to recently file an application for licenses and expressed confidence of a government approval, however is not guaranteed. Additional updates and details on these discussions including a possible agreement are expected to be announced shortly. A Non Disclosure Agreement as well as requests being made to Easto...

More updates from Easton Pharmaceuticals Inc